AbstractWe previously identified a novel amyloid β-protein (Aβ), that binds to GM1 ganglioside, in brains exhibiting the early pathological changes of AD. In this study, we raised monoclonal antibodies, using membrane fractions containing abundant GM1 ganglioside-bound Aβ as antigens. Monoclonal antibody 4396, produced in this study, immunoprecipitates Aβ42 in the membrane fractions of brains with diffuse plaques, but does not react with soluble Aβ42 or GM1 ganglioside. Furthermore, this antibody recognizes the Aβ bound to lipid vesicles containing GM1 ganglioside, and unexpectedly, phosphatidylinositol. In contrast, a control anti-Aβ monoclonal antibody does not recognize the Aβ bound to these lipid vesicles. These results indicate that Aβ...
AbstractThe interaction between Alzheimer amyloid peptide Aβ(1–40) and membrane lipids was studied b...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Aggregates of amyloid-β (Aβ) are characteristic of Alzheimer’s disease, but there is no consensus as...
AbstractWe previously identified a novel amyloid β-protein (Aβ), that binds to GM1 ganglioside, in b...
While the molecular mechanisms underlying Alzheimer's disease (AD) remain largely unknown, abnormal ...
SummarySoluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer’s disease, but th...
AbstractThe deposition of amyloid β-protein (Aβ) is an invariable feature of Alzheimer's disease (AD...
Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder that affects cognition and m...
AbstractOne of the fundamental questions regarding the pathogenesis of Alzheimer’s disease (AD) is h...
AbstractPrior to the identification of the various abnormal proteins deposited as fibrillar aggregat...
AbstractA hallmark of the common Alzheimer's disease (AD) is the pathological conversion of its amph...
The interaction of amyloid β-proteins (Aβ) with membrane gangliosides has been reported to be an ear...
International audienceAlterations in the lipid composition of endosomal-lysosomal membranes may cons...
Amyloid β peptide (Aβ) is the crucial protein component of extracellular plaques in Alzheimer’s dise...
The interaction of the amyloid-β protein (Aβ) with neuronal cell membranes plays a crucial role in A...
AbstractThe interaction between Alzheimer amyloid peptide Aβ(1–40) and membrane lipids was studied b...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Aggregates of amyloid-β (Aβ) are characteristic of Alzheimer’s disease, but there is no consensus as...
AbstractWe previously identified a novel amyloid β-protein (Aβ), that binds to GM1 ganglioside, in b...
While the molecular mechanisms underlying Alzheimer's disease (AD) remain largely unknown, abnormal ...
SummarySoluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer’s disease, but th...
AbstractThe deposition of amyloid β-protein (Aβ) is an invariable feature of Alzheimer's disease (AD...
Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder that affects cognition and m...
AbstractOne of the fundamental questions regarding the pathogenesis of Alzheimer’s disease (AD) is h...
AbstractPrior to the identification of the various abnormal proteins deposited as fibrillar aggregat...
AbstractA hallmark of the common Alzheimer's disease (AD) is the pathological conversion of its amph...
The interaction of amyloid β-proteins (Aβ) with membrane gangliosides has been reported to be an ear...
International audienceAlterations in the lipid composition of endosomal-lysosomal membranes may cons...
Amyloid β peptide (Aβ) is the crucial protein component of extracellular plaques in Alzheimer’s dise...
The interaction of the amyloid-β protein (Aβ) with neuronal cell membranes plays a crucial role in A...
AbstractThe interaction between Alzheimer amyloid peptide Aβ(1–40) and membrane lipids was studied b...
Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerati...
Aggregates of amyloid-β (Aβ) are characteristic of Alzheimer’s disease, but there is no consensus as...